Essex Investment Management Co. LLC Grows Position in Nutex Health Inc. (NASDAQ:NUTX)

Essex Investment Management Co. LLC raised its holdings in shares of Nutex Health Inc. (NASDAQ:NUTXFree Report) by 45.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 105,809 shares of the company’s stock after acquiring an additional 33,024 shares during the quarter. Essex Investment Management Co. LLC’s holdings in Nutex Health were worth $3,353,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Beaird Harris Wealth Management LLC purchased a new stake in Nutex Health during the third quarter valued at about $69,000. Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health during the fourth quarter valued at about $206,000. State Street Corp bought a new stake in shares of Nutex Health during the third quarter valued at about $225,000. Thompson Davis & CO. Inc. bought a new stake in shares of Nutex Health during the third quarter valued at about $494,000. Finally, Legato Capital Management LLC increased its position in shares of Nutex Health by 26.8% during the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock valued at $1,004,000 after buying an additional 6,697 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Trading Down 4.0 %

Shares of NUTX opened at $44.66 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The business’s 50-day moving average price is $46.40 and its 200-day moving average price is $33.43. The stock has a market cap of $242.82 million, a PE ratio of -4.76 and a beta of 0.01. Nutex Health Inc. has a twelve month low of $4.16 and a twelve month high of $69.45.

Analyst Upgrades and Downgrades

NUTX has been the topic of several analyst reports. Maxim Group upped their price target on Nutex Health from $50.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Benchmark upped their price target on Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a research report on Tuesday, November 12th.

View Our Latest Research Report on NUTX

Nutex Health Profile

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Read More

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTXFree Report).

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.